MAPT and Alzheimer disease: Second, a definitive diagnosis of AD cannot be made without confirmation by autopsy, so physicians and scientists have to rely on biomarkers (e.g., measuring Aβ, tau, or p-tau in cerebrospinal fluid (CSF) or plasma, or Aβ deposition in the brain using positron emission tomography (PET) imaging) to make diagnoses as accurate as possible.